TNDM

18.64

1.58% -0.30

시장 영업 전: 17.70 -0.94 -5.04%

Tandem Diabetes Care Inc (TNDM)

개요 뉴스 가격 이력 옵션 체인 Financials TNDM 왜 하락? 토론 예측 주식 분할

전일 마감가:

$18.94

열려 있는:

$18.955

하루 거래량:

1.24M

Relative Volume:

0.84

시가총액:

$1.49B

수익:

$796.00M

순이익/손실:

$-136.49M

주가수익비율:

-8.9187

EPS:

-2.09

순현금흐름:

$-64.24M

1주 성능:

-7.81%

1개월 성능:

-5.95%

6개월 성능:

-48.25%

1년 성능:

-53.74%

1일 변동 폭

$18.57

$19.23

1주일 범위

$18.54

$21.18

52주 변동 폭

$15.75

$48.24

Tandem Diabetes Care Inc Stock (TNDM) Company Profile

명칭

Tandem Diabetes Care Inc

부문

Healthcare (1173)

산업

Medical Devices (149)

전화

858-366-6900

주소

12400 HIGH BLUFF DRIVE, San Diego, CA

직원

2,650

트위터

@tandemdiabetes

다음 수익 날짜

2024-11-06

최신 SEC 제출 서류

TNDM's Discussions on Twitter

TNDM을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
TNDM Tandem Diabetes Care Inc	18.64	1.49B	796.00M	-136.49M	-64.24M	-2.09
ABT Abbott Laboratories	136.01	233.36B	42.34B	13.50B	6.66B	7.71
BSX Boston Scientific Corp	107.41	147.06B	17.55B	2.03B	2.72B	1.37
SYK Stryker Corp	395.63	145.64B	23.22B	2.86B	3.58B	7.40
MDT Medtronic Plc	87.17	112.76B	33.54B	4.66B	5.19B	3.62
EW Edwards Lifesciences Corp	78.21	44.46B	5.54B	4.18B	623.10M	7.00

Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-06-16	개시	Truist	Hold
2025-04-10	개시	Mizuho	Neutral
2025-03-05	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2025-03-04	다운그레이드	Citigroup	Buy → Neutral
2025-03-03	다운그레이드	Wells Fargo	Overweight → Equal Weight
2025-02-28	다운그레이드	Bernstein	Outperform → Mkt Perform
2024-12-02	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2024-11-06	개시	Bernstein	Outperform
2024-10-04	개시	Goldman	Neutral
2024-10-02	개시	RBC Capital Mkts	Outperform
2024-08-22	개시	Morgan Stanley	Equal-Weight
2024-08-08	개시	Canaccord Genuity	Buy
2024-05-30	개시	Redburn Atlantic	Buy
2024-05-22	업그레이드	Citigroup	Neutral → Buy
2024-04-29	업그레이드	Wells Fargo	Equal Weight → Overweight
2024-04-25	업그레이드	Leerink Partners	Market Perform → Outperform
2024-03-26	업그레이드	Stifel	Hold → Buy
2023-08-04	다운그레이드	Citigroup	Buy → Neutral
2023-05-05	다운그레이드	BofA Securities	Neutral → Underperform
2023-04-24	다운그레이드	Raymond James	Outperform → Mkt Perform
2023-03-29	개시	UBS	Neutral
2023-01-26	개시	Wolfe Research	Peer Perform
2022-11-15	업그레이드	Wells Fargo	Underweight → Equal Weight
2022-10-18	개시	Barclays	Overweight
2022-10-12	개시	Jefferies	Buy
2022-08-09	다운그레이드	Wells Fargo	Overweight → Underweight
2022-03-02	재개	BofA Securities	Neutral
2022-01-19	업그레이드	Wells Fargo	Equal Weight → Overweight
2021-07-21	재개	Cowen	Outperform
2021-05-25	개시	Barclays	Underweight
2020-12-15	다운그레이드	Wells Fargo	Overweight → Equal Weight
2020-08-20	개시	Wells Fargo	Overweight
2020-07-31	업그레이드	Guggenheim	Neutral → Buy
2020-07-06	업그레이드	Citigroup	Neutral → Buy
2020-06-18	재확인	Raymond James	Outperform
2020-04-24	다운그레이드	SVB Leerink	Outperform → Mkt Perform
2020-03-23	다운그레이드	Guggenheim	Buy → Neutral
2020-03-05	개시	Citigroup	Neutral
2020-02-06	개시	Raymond James	Outperform
2020-02-04	다운그레이드	Robert W. Baird	Outperform → Neutral
2019-10-18	개시	Guggenheim	Buy
2019-10-04	업그레이드	UBS	Neutral → Buy
2019-05-17	재확인	BofA/Merrill	Neutral
2019-05-13	개시	SVB Leerink	Outperform
2019-03-08	개시	BMO Capital Markets	Outperform
2019-03-05	재확인	BofA/Merrill	Neutral
2019-02-27	재확인	Lake Street	Buy
2018-11-21	업그레이드	Robert W. Baird	Neutral → Outperform
2018-09-26	재확인	Dougherty & Company	Buy
2018-09-26	재확인	Piper Jaffray	Overweight

모두보기

Tandem Diabetes Care Inc 주식(TNDM)의 최신 뉴스

Jun 18, 2025

Abbott, Tandem Diabetes Care Partner For Glucose-Ketone Sensor for Diabetes Management - MSN

Jun 18, 2025

Jun 17, 2025

How To Trade (TNDM) - news.stocktradersdaily.com

Jun 17, 2025

Digital Diabetes Management Market 2025Growth in Apps, - openPR.com

Jun 17, 2025

Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities - FinancialContent

Jun 17, 2025

What Does Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) Share Price Indicate? - Yahoo Finance

Jun 17, 2025

Tandem Diabetes Care’s SWOT analysis: stock faces growth hurdles amid market shifts - Investing.com Nigeria

Jun 17, 2025

Jun 16, 2025

TNDM: Truist Securities Initiates Coverage with Hold Rating | TN - GuruFocus

Jun 16, 2025

TNDM: Truist Securities Initiates Coverage with Hold Rating | TNDM Stock News - GuruFocus

Jun 16, 2025

10 Best Stocks to Buy For Beginners Now - Insider Monkey

Jun 16, 2025

Truist bullish on diabetes companies citing potential market growth - Seeking Alpha

Jun 16, 2025

Truist initiates Tandem Diabetes Care stock with hold rating By Investing.com - Investing.com Canada

Jun 16, 2025

Tandem Diabetes (TNDM) Receives Hold Rating from Truist | TNDM S - GuruFocus

Jun 16, 2025

Truist Initiates Tandem Diabetes Care at Hold With $24 Price Target - MarketScreener

Jun 16, 2025

Jun 11, 2025

Abbott Laboratories (NYSE:ABT) Partners With Tandem To Develop Dual Sensor Diabetes Solutions - simplywall.st

Jun 11, 2025

Jun 10, 2025

Tandem, Abbott team on insulin delivery with glucose-ketone sensor - MedTech Dive

Jun 10, 2025

Abbott to pair glucose-ketone sensor with Tandem's insulin pumps - Modern Healthcare

Jun 10, 2025

Tandem Diabetes Care Announces Agreement with Abbott for Integration of Automated Insulin Delivery Systems with Future Glucose-Ketone Sensor - MarketScreener

Jun 10, 2025

Tandem Diabetes Inks Deal With Abbott For New Diabetes Solutions: Retail Sentiment Stays Subdued By Stocktwits - Investing.com India

Jun 10, 2025

Tandem Diabetes Inks Deal With Abbott For New Diabetes Solutions: Retail Sentiment Stays Subdued - Asianet Newsable

Jun 10, 2025

Diabetes partnerships abound ahead of ADA - BioWorld MedTech

Jun 10, 2025

Tandem Diabetes at Goldman Sachs Conference: Strategic Growth Insights By Investing.com - Investing.com Canada

Jun 10, 2025

Transcript : Tandem Diabetes Care, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 08 - MarketScreener

Jun 10, 2025

Tandem Diabetes (TNDM) Partners with Abbott for Innovative Diabe - GuruFocus

Jun 10, 2025

Tandem, Abbott in deal to combine insulin delivery with glucose-ketone sensor - Seeking Alpha

Jun 10, 2025

Tandem Diabetes Care Announces Agreement With Abbott For Integration Of Automated Insulin Delivery Systems With Future Glucose-Ketone Sensor - marketscreener.com

Jun 10, 2025

Tandem Diabetes, Abbott to Merge Insulin Pump with Future Glucose-Ketone Sensor - Medical Product Outsourcing

Jun 10, 2025

Abbott (ABT) Partners with Tandem Diabetes for Advanced Diabetes Management Solutions | ABT Stock News - GuruFocus

Jun 10, 2025

Tandem Diabetes Care Announces Agreement with Abbott for Integration of Automated Insulin Delivery Systems with Future Glucose-Ketone Sensor | TNDM Stock News - GuruFocus

Jun 10, 2025

3 Reasons to Sell TNDM and 1 Stock to Buy Instead - Yahoo Finance

Jun 10, 2025

Jun 09, 2025

Transcript : Tandem Diabetes Care, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 03 - MarketScreener

Jun 09, 2025

Tandem to pay Roche $36M in patent dispute settlement - MSN

Jun 09, 2025

Jun 05, 2025

Tandem Diabetes Care: A Barbell Bet On A High-Stakes Turnaround (NASDAQ:TNDM) - Seeking Alpha

Jun 05, 2025

Jun 04, 2025

(TNDM) Long Term Investment Analysis - news.stocktradersdaily.com

Jun 04, 2025

Tandem Diabetes at Jefferies: Expanding Market Horizons By Investing.com - Investing.com Canada

Jun 04, 2025

How the Non-Invasive Drug Delivery Device Market Will Evolve - openPR.com

Jun 04, 2025

Do You Believe in the Long-Term Growth Potential of Tandem Diabetes Care (TNDM)? - Insider Monkey

Jun 04, 2025

Jun 03, 2025

Roche settles UPC dispute over insulin distribution technology - JUVE Patent

Jun 03, 2025

Jun 02, 2025

Goldman Sachs Bullish On Dexcom And Insulet As Diabetes Tech Surges - Benzinga

Jun 02, 2025

May 31, 2025

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives Average Recommendation of “Hold” from Analysts - Defense World

May 31, 2025

May 30, 2025